HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leishmaniasis: current status of vaccine development.

Abstract
Leishmaniasis, a spectrum of diseases caused by various forms of Leishmania has become a major health problem all over the world. Vaccination against leishmaniasis has passed through many developmental stages beginning with the ancient practice of 'leishmanization'. Due to various problems and difficulties associated with traditional vaccines, the interest has been shifted to novel approaches of vaccination like DNA vaccination, vaccination with live vectors encoding leishmanial antigens and finally to designer vaccines. In an effort towards developing an anti-leishmanial vaccine, our laboratory has been working on various genes present in an amplified locus of Leishmania known as the 'LD1 locus'. Two genes, ORFF and BT1 (previously ORFG), are part of the multigenic LD1 locus on chromosome 35. BT1 encodes a biopterin transporter, while the function of ORFF gene product is unknown. Immunization of mice with recombinant ORFF (rORFF) and BT1 proteins, individually, or in combination, conferred partial protection against challenge with Leishmania donovani. We also tested the protective efficacy of ORFF DNA vaccine in BALB/c mice model and found that the level of protection was significantly higher than that of ORFF protein. Protection conferred by ORFF DNA vaccine correlated with significant levels of in vitro splenocyte proliferation and low levels of antigen-specific antibodies. There was a preferential production of IFN-gamma compared to IL-4, which indicated the induction of a protective Th1 response, by the DNA vaccine. Thus, DNA immunization may offer an attractive alternative strategy against leishmaniasis. We present here the current status of vaccine development against leishmaniasis.
AuthorsBindu Sukumaran, Rentala Madhubala
JournalCurrent molecular medicine (Curr Mol Med) Vol. 4 Issue 6 Pg. 667-79 (Sep 2004) ISSN: 1566-5240 [Print] Netherlands
PMID15357215 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antigens, Protozoan
  • Protozoan Proteins
  • Protozoan Vaccines
  • Vaccines, DNA
  • Interferon-gamma
Topics
  • Animals
  • Antigens, Protozoan (immunology)
  • Cell Division
  • Genes, Protozoan (immunology)
  • Interferon-gamma (biosynthesis)
  • Leishmania donovani (genetics, immunology, isolation & purification)
  • Leishmaniasis (immunology, parasitology, prevention & control)
  • Liver (immunology, parasitology)
  • Mice
  • Mice, Inbred BALB C
  • Protozoan Proteins (biosynthesis, genetics, immunology)
  • Protozoan Vaccines (immunology)
  • Spleen (immunology, parasitology)
  • Th1 Cells (immunology)
  • Vaccination
  • Vaccines, DNA (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: